Excellent Overall Survival And Low Incidence Of Late Effects In Patients Undergoing Allogeneic Hematopoietic Cell Transplant For Sickle Cell Disease: A Report From The Center For International Blood And Marrow Transplant Research (Cibmtr)
BLOOD（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要